Valsartil 80 mg is an oral antihypertensive medication that belongs to the class of angiotensin II receptor blockers (ARBs). It is designed to manage high blood pressure (hypertension), reduce hospitalizations in patients with congestive heart failure, and decrease mortality in patients who develop heart failure after a myocardial infarction.
Valsartil works by blocking the effects of angiotensin II, a hormone responsible for vasoconstriction (narrowing of blood vessels). This leads to relaxation of blood vessels, reduction in blood pressure, and improved blood flow without significantly affecting heart rate. It exhibits a high specificity for the AT1 receptor, ensuring targeted cardiovascular action while minimizing off-target effects.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Angiotensin II Receptor Blocker (ARB)
Valsartil 80 mg is indicated for:
Hypertension – To lower elevated blood pressure and reduce the risk of cardiovascular complications.
Congestive Heart Failure (CHF) – To reduce hospitalizations in patients with symptomatic heart failure.
Post-Myocardial Infarction Heart Failure – To reduce mortality in patients who develop heart failure after a heart attack.
Mechanism of Action: Valsartil selectively blocks angiotensin II AT1 receptors, preventing vasoconstriction and aldosterone-mediated sodium and water retention. This results in vasodilation, lower blood pressure, and decreased cardiac workload.
Pharmacokinetics:
Orally active with peak plasma concentration in 2–4 hours
Excreted primarily via bile and minimally through urine
Does not undergo significant metabolism, minimizing drug-drug interactions
Hypertension:
Typical dose: 80–160 mg once daily
Maximum dose: 320 mg daily
Maximum effect is usually observed within 4 weeks
Heart Failure:
Initial dose: 40 mg twice daily
May be increased to 80–160 mg twice daily based on tolerance
Post-Myocardial Infarction:
Initial dose: 20 mg twice daily
Titrate to a target dose of 160 mg daily as tolerated
Administration Tips:
Take on an empty stomach as food decreases absorption by ~40%
No initial dose adjustment needed for elderly patients with mild to moderate renal or hepatic insufficiency
Valsartil has minimal clinically significant interactions
Studied drugs include Cimetidine, Warfarin, Furosemide, Digoxin, Atenolol, Indomethacin, Hydrochlorothiazide, Amlodipine, Glibenclamide
Concomitant use with potassium-sparing diuretics or potassium supplements may increase serum potassium; monitor levels carefully
Hypersensitivity to Valsartil or any formulation component
Severe hepatic impairment
Pregnancy (2nd and 3rd trimester)
Generally well tolerated. Common side effects include:
Headache, dizziness, fatigue
Abdominal pain, diarrhea, nausea
Hyperkalemia, hypotension (especially with diuretics)
Less common: rash, muscle cramps, vertigo, insomnia, dyspnea, impotence
Hepatic Impairment: Use cautiously; maximum 80 mg daily for mild/moderate impairment
Renal Impairment: Dose reduction or discontinuation may be needed
Heart Failure/Myocardial Infarction: Start therapy with caution
Pregnancy: Contraindicated in 2nd/3rd trimester due to risk of fetal injury
Nursing: Use caution; effect on breast milk is unknown
Most likely manifestations: hypotension, tachycardia; bradycardia may occur
Management: Place patient supine, administer intravenous normal saline if necessary
Pediatric: Safety not established
Geriatric: No overall efficacy difference, but increased sensitivity in some elderly
Hepatic Impairment: Mild/moderate: 80 mg once daily; severe: contraindicated
Store at 15–30°C, protected from heat and moisture
Keep out of reach of children
Valsartil 80 mg is a selective angiotensin II AT1 receptor antagonist. By blocking angiotensin II, it prevents vasoconstriction and sodium retention, leading to vasodilation, reduced blood pressure, and decreased cardiac stress without affecting the heart rate. Its high specificity minimizes side effects related to other hormone receptors or ion channels.
Should not be used during pregnancy, particularly 2nd and 3rd trimester
Nursing mothers: Use caution; weigh importance of therapy vs. potential infant risk.
Login Or Registerto submit your questions to seller
No none asked to seller yet